Jeeyeon Shin

Jeeyeon Shin

Auto-generated profile, based on publicly available information

Jeeyeon Shin

Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SKSeunghyun Lewis Kwon
Seunghyun Lewis Kwon
BSBan Seon-Hwa
Ban Seon-Hwa
JSJeeyeon Shin
Jeeyeon Shin
HBHyuna Bae
Hyuna Bae
HPHeeyoun Park
Heeyoun Park
GKGeun-Yong Kwon
Geun-Yong Kwon
Kwon SL, et al. J Korean Med Sci. 2022 Jul;37(29):e239. https://doi.org/10.3346/jkms.2022.37.e239

13 December 2022 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
HCHye-Kyung Cho
Hye-Kyung Cho
HLHyunju Lee
Hyunju Lee
YCYoung June Choe
Young June Choe
SKShinkyeong Kim
Shinkyeong Kim
SSSujin Seo
Sujin Seo
MYMyoungsoon You
Myoungsoon You
OBJECTIVES: Vaccination is one of the most important strategies to contain the spread of coronavirus disease 2019 (COVID-19). Vaccination in children is dependent on their parents, making it important to understand parents’ awareness and attitudes toward vaccines in order to devise strategies to raise vaccination rates in children.METHODS: A web-based nationwide survey was conducted among Korean parents of 7-year-old to 18-year-old children in August 2021 to estimate parents’ intention to vaccinate their children against COVID-19 and identify key factors affecting parental acceptance and hesitancy through regression analysis.RESULTS: Approximately 56.4% (575/1,019) were willing to vaccinate their children against COVID-19. Contributing factors to COVID-19 vaccine hesitancy were being a mother (adjusted odds ratio [aOR], 0.36; 95% confidence interval [CI], 0.25 to 0.52), a lower education level (aOR, 0.83; 95% CI, 0.70 to 0.97), hesitancy to other childhood vaccines (aOR, 0.78; 95% CI, 0.64 to 0.96), and refusal to vaccinate themselves (aOR, 0.08; 95% CI, 0.02 to 0.20). Having older children (aOR, 1.20; 95% CI, 1.13 to 1.28), trusting the child’s doctor (aOR, 1.19; 95% CI, 1.07 to 1.32), positive perceptions of the COVID-19 vaccine’s effectiveness (aOR, 2.60; 95% CI, 1.90 to 3.57) and perceiving the COVID-19 vaccine as low-risk (aOR, 1.68; 95% CI, 1.27 to 2.24) were associated with COVID-19 vaccine acceptance. Concerns about adverse reactions were the most common cause of hesitancy.CONCLUSIONS: Providing parents with accurate and reliable information on vaccine effectiveness and safety is important to increase COVID-19 vaccine uptake in children. Differential or targeted approaches to parents according to gender, age, and their children’s age are necessary for effective communication about vaccination in children.

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SPSeon Kyeong Park
Seon Kyeong Park
YCYoung June Choe
Young June Choe
EJEun Jung Jang
Eun Jung Jang
RKRyu Kyung Kim
Ryu Kyung Kim
SLSang-Won Lee
Sang-Won Lee
YPYoung-Joon Park
Young-Joon Park
Park SK, et al. J Korean Med Sci. 2023 Apr;38(19):e143. https://doi.org/10.3346/jkms.2023.38.e143

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SKSeunghyun Lewis Kwon
Seunghyun Lewis Kwon
MSMinju Song
Minju Song
WLWonkyung Lee
Wonkyung Lee
JSJeeyeon Shin
Jeeyeon Shin
SLSu-Yeon Lee
Su-Yeon Lee
SLSookyoung Lim
Sookyoung Lim
Kwon SL, et al. J Korean Med Sci. 2024 Jul;39:e235. https://doi.org/10.3346/jkms.2024.39.e235

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
CKCho Ryok Kang
Cho Ryok Kang
YCYoung June Choe
Young June Choe
JSJeeyeon Shin
Jeeyeon Shin
HJHang Jin Jeong
Hang Jin Jeong
SKSunghee Kwon
Sunghee Kwon
HLHyunju Lee
Hyunju Lee
Kang CR, et al. J Korean Med Sci. 2024 Jun;39(25):e193. https://doi.org/10.3346/jkms.2024.39.e193

25 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JLJinhee Lee
Jinhee Lee
HKHee-Yeon Kang
Hee-Yeon Kang
HLHyunju Lee
Hyunju Lee
KMKyung-Jin Min
Kyung-Jin Min
JSJee Yeon Shin
Jee Yeon Shin
JOJin-Kyoung Oh
Jin-Kyoung Oh
IntroductionSouth Korea introduced a national two-dose human papillomavirus (HPV) immunization program for 12-year-old girls in 2016. We assessed its early real-world effectiveness against anogenital warts.MethodsIn this nationwide retrospective cohort study, we linked the Korea Disease Control and Prevention Agency immunization registry to the National Health Insurance Service database. Females born in 2003–12 were classified by HPV vaccine type and number of doses received before a birth cohort-specific administrative vaccination deadline. Participants were followed until an incident diagnosis of anogenital warts, death, or December 31, 2024. Incidence rate ratios were estimated with Poisson regression, and vaccine effectiveness was calculated as one minus the incidence rate ratio.ResultsThe analysis included 2,184,929 females, of whom 1,529,835 had received the quadrivalent or nonavalent vaccine and 655,094 were included in the comparison group. The adjusted effectiveness of at least one dose against anogenital warts was 58.4% (95% CI 53.1–63.2). Adjusted effectiveness was 56.2% (49.9–61.7) after two doses and 52.8% (37.1–64.6) after one dose. Effectiveness was 55.8% (49.1–61.7) in the 2003–04 birth cohorts, 64.0% (53.4–72.2) in the 2005–06 cohorts, and 64.9% (44.0–78.0) in the 2007–10 cohorts.DiscussionHPV vaccination through South Korea’s national program was associated with a substantially lower incidence of anogenital warts. Protection was observed after both one and two doses, although this observational study was not designed to establish equivalence between the schedules. Continued follow-up is needed to assess effectiveness against cervical precancer and cancer.